Taken together, our findings highlight that the aberrantly expressed NKL homeobox genes NKX2-3 and NKX2-4 manipulate developmental lineage decisions in respective megakaryoblastic and erythroblastic AML via FLI1 deregulation and SIX5 activation. The gene discussed is SIX5; the disease is acute myeloid leukemia.